Evidence mapPaperPMID 41799952Full record

ArticleBioactive materials2026

pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity.

Fangfang Li, Kun Su, Fraooq Riaz, Chunyu Liu, Ping Wei, Xian Li, Kaimin Zhang, Taowen Zhao, Wen Xu, Xiaoli Zhao and 5 more

Abstract read
In one paragraph

Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fangfang LiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Kun SuShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Fraooq RiazFaculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, 518107, PR China.
Chunyu LiuShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Ping WeiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Xian LiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Kaimin ZhangFaculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, 518107, PR China.
Taowen ZhaoShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Wen XuShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Xiaoli ZhaoShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
William Weijia LuShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Qiang YangDepartment of Spine Surgery, Tianjin Hospital, Tianjin University, Tianjin, 300211, PR China.
Limin ZhaoGeriatric Medicine Department & Health Management Center, Shenzhen University of Advanced Technology General Hospital, Shenzhen, 512000, PR China.
Fan PanShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.
Haobo PanShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, Shenzhen, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acidic tumor microenvironment (TME) promotes immune escape by suppressing T-cell function, creating a major barrier to immunotherapy. Here, acidic pH-mediated impairment of T cell responses via the proton-sensing receptor GPCR68 is identified, whereas mild extracellular alkalinization counteracts this pathway to restore T cell effector function. GPCR68 acts as a negative regulator of T cell-driven anti-tumor immunity, as evidenced by the enhanced cytokine production (IFN-γ, TNF-α) and suppressed tumor growth in T cell-specific GPCR68 knockout mice (GPCR68

Indexed as

Acidic tumor microenvironmentFerroptosisGPCR68ImmunoreprogrammingImmunotherapy sensitizationpH-neutralization strategy

Identifiers

PMID41799952
PMCPMC12963920

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.